159 related articles for article (PubMed ID: 23935199)
1. Oropharyngeal group A streptococcal colonization disrupts latent Epstein-Barr virus infection.
Ueda S; Uchiyama S; Azzi T; Gysin C; Berger C; Bernasconi M; Harabuchi Y; Zinkernagel AS; Nadal D
J Infect Dis; 2014 Jan; 209(2):255-64. PubMed ID: 23935199
[TBL] [Abstract][Full Text] [Related]
2. Examining the dynamics of Epstein-Barr virus shedding in the tonsils and the impact of HIV-1 coinfection on daily saliva viral loads.
Byrne CM; Johnston C; Orem J; Okuku F; Huang ML; Rahman H; Wald A; Corey L; Schiffer JT; Casper C; Coombs D; Gantt S
PLoS Comput Biol; 2021 Jun; 17(6):e1009072. PubMed ID: 34153032
[TBL] [Abstract][Full Text] [Related]
3. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of streptococcal or Epstein-Barr virus infections in children with acute non-septic monoarthritis.
Di Loreto S; Fabiano C; Nigro G
New Microbiol; 2014 Jan; 37(1):81-6. PubMed ID: 24531174
[TBL] [Abstract][Full Text] [Related]
5. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
6. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.
Araujo I; Foss HD; Hummel M; Anagnostopoulos I; Barbosa HS; Bittencourt A; Stein H
J Pathol; 1999 Feb; 187(3):326-30. PubMed ID: 10398087
[TBL] [Abstract][Full Text] [Related]
7. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
9. Latent and lytic Epstein-Barr virus replication strategies.
Tsurumi T; Fujita M; Kudoh A
Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
[TBL] [Abstract][Full Text] [Related]
10. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
11. A molecular link between malaria and Epstein-Barr virus reactivation.
Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
[TBL] [Abstract][Full Text] [Related]
12. Pediatric epstein-barr virus carriers with or without tonsillar enlargement may substantially contribute to spreading of the virus.
Hug M; Dorner M; Fröhlich FZ; Gysin C; Neuhaus D; Nadal D; Berger C
J Infect Dis; 2010 Oct; 202(8):1192-9. PubMed ID: 20815705
[TBL] [Abstract][Full Text] [Related]
13. Detection of specific lytic and latent transcripts can help to predict the status of Epstein-Barr virus infection in transplant recipients with high virus load.
Zawilinska B; Kosinska A; Lenart M; Kopec J; Piatkowska-Jakubas B; Skotnicki A; Kosz-Vnenchak M
Acta Biochim Pol; 2008; 55(4):693-9. PubMed ID: 19015775
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads.
Qu L; Green M; Webber S; Reyes J; Ellis D; Rowe D
J Infect Dis; 2000 Oct; 182(4):1013-21. PubMed ID: 10979894
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection.
Iwata S; Wada K; Tobita S; Gotoh K; Ito Y; Demachi-Okamura A; Shimizu N; Nishiyama Y; Kimura H
J Gen Virol; 2010 Jan; 91(Pt 1):42-50. PubMed ID: 19793909
[TBL] [Abstract][Full Text] [Related]
16. Detection of lymphocytes productively infected with Epstein-Barr virus in non-neoplastic tonsils.
Ikeda T; Kobayashi R; Horiuchi M; Nagata Y; Hasegawa M; Mizuno F; Hirai K
J Gen Virol; 2000 May; 81(Pt 5):1211-6. PubMed ID: 10769062
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country.
Vistarop AG; Cohen M; De Matteo E; Preciado MV; Chabay PA
Sci Rep; 2016 Mar; 6():23303. PubMed ID: 26988293
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
19. Epstein-barr virus diversity in immunocompetent healthy persons: reassessment of the distribution of genetic variants.
Ikeda T; Kobayashi R; Kogashiwa Y; Matsuda T; Kohno N
J Med Virol; 2014 Feb; 86(2):301-5. PubMed ID: 24026669
[TBL] [Abstract][Full Text] [Related]
20. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
